Patents by Inventor Georg Maiwald

Georg Maiwald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
    Patent number: 5866694
    Abstract: This invention concerns peptides binding to antibodies which show neutralizing activity against different strains and clinical isolates of HIV-1 and which inhibit the fusion of cells infected with HIV-1. These peptides are combined with an adjuvant, as recombinant fusion proteins, chemically coupled to carrier molecules, as recombinant chimeric viruses or as recombinant antibodies.
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: February 2, 1999
    Assignee: Hermann Katinger
    Inventors: Hermann Katinger, Florian Ruker, Gottfried Himmler, Thomas Muster, Alexandra Trkola, Martin Purtscher, Georg Maiwald, Franz Steindl
  • Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
    Patent number: 5756674
    Abstract: The present invention relates to fusion peptides wherein at least one peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 25 is bound to an adjuvant being a protein molecule by fusion of the respective nucleotide sequences and subsequent expression of the fusion genes in a biological expression system.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 26, 1998
    Assignee: Herman Katinger
    Inventors: Hermann Katinger, Florian Ruker, Gottfried Himmler, Thomas Muster, Alexandra Trkola, Martin Purtscher, Georg Maiwald, Franz Steindl
  • Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
    Patent number: 5693752
    Abstract: This invention refers to peptides binding to antibodies that show neutralizing activity against different strains and clinical isolates of HIV-1 and that inhibit the fusion of cells caused by HIV-1. These peptides are applied with an adjuvant, as recombinant fusion proteins, chemically coupled to carrier molecules, as recombinant chimeric viruses or as recombinant antibodies.
    Type: Grant
    Filed: December 22, 1994
    Date of Patent: December 2, 1997
    Assignee: Hermann Katinger
    Inventors: Hermann Katinger, Florian Ruker, Gottfried Himmler, Thomas Muster, Alexandra Trkola, Martin Purtscher, Georg Maiwald, Franz Steindl